Growth Metrics

Evolent Health (EVH) Debt to Equity (2019 - 2026)

Evolent Health has reported Debt to Equity over the past 7 years, most recently at $2.34 for Q4 2025.

  • For Q4 2025, Debt to Equity rose 253.56% year-over-year to $2.34; the TTM value through Dec 2025 reached $2.34, up 253.56%, while the annual FY2025 figure was $2.34, 253.56% up from the prior year.
  • Debt to Equity for Q4 2025 was $2.34 at Evolent Health, up from $1.26 in the prior quarter.
  • Over five years, Debt to Equity peaked at $2.34 in Q4 2025 and troughed at $0.31 in Q4 2021.
  • A 5-year average of $0.67 and a median of $0.56 in 2023 define the central range for Debt to Equity.
  • Biggest five-year swings in Debt to Equity: fell 1.87% in 2024 and later soared 253.56% in 2025.
  • Year by year, Debt to Equity stood at $0.31 in 2021, then skyrocketed by 54.55% to $0.48 in 2022, then grew by 16.37% to $0.56 in 2023, then grew by 18.23% to $0.66 in 2024, then soared by 253.56% to $2.34 in 2025.
  • Business Quant data shows Debt to Equity for EVH at $2.34 in Q4 2025, $1.26 in Q3 2025, and $0.92 in Q2 2025.